These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15357042)
1. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency. Edson RS; Brey RH; McDonald TJ; Terrell CL; McCarthy JT; Thibert JM Mayo Clin Proc; 2004 Sep; 79(9):1185-91. PubMed ID: 15357042 [TBL] [Abstract][Full Text] [Related]
2. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient. Ahya VN; Doyle AM; Mendez JD; Lipson DA; Christie JD; Blumberg EA; Pochettino A; Nelson L; Bloom RD; Kotloff RM J Heart Lung Transplant; 2005 Jul; 24(7):932-5. PubMed ID: 15982625 [TBL] [Abstract][Full Text] [Related]
3. Vestibulotoxicity in a patient without renal failure after inhaled tobramycin. Kaufman AC; Eliades SJ Am J Otolaryngol; 2019; 40(3):456-458. PubMed ID: 30910434 [TBL] [Abstract][Full Text] [Related]
4. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482 [TBL] [Abstract][Full Text] [Related]
5. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142 [TBL] [Abstract][Full Text] [Related]
6. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
7. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection]. Mordasini C; Aebischer CC; Schoch OD Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818 [TBL] [Abstract][Full Text] [Related]
8. [Use of inhaled tobramycin in patients with cystic fibrosis]. Chermenskiĭ AG; Gembitskaia TE Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251 [TBL] [Abstract][Full Text] [Related]
9. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure. Patatanian L Pediatr Infect Dis J; 2006 Mar; 25(3):276-8. PubMed ID: 16511399 [TBL] [Abstract][Full Text] [Related]
10. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641 [TBL] [Abstract][Full Text] [Related]
11. Elevated serum tobramycin concentrations after treatment with tobramycin inhalation in a preterm infant. Abdulhamid I; Wise TL; Andrews S; Biglin K; Lehr VT Pharmacotherapy; 2008 Jul; 28(7):939-44. PubMed ID: 18576909 [TBL] [Abstract][Full Text] [Related]
12. [Case reports of the treatment with tobramycin solution for inhalation in severe bronchiectasis patients continuous infection of Pseudomonas aeruginosa]. Nakamura S; Yanagihara K; Morinaga Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Tashiro T; Kohno S Nihon Kokyuki Gakkai Zasshi; 2005 Jan; 43(1):41-7. PubMed ID: 15704452 [TBL] [Abstract][Full Text] [Related]
13. Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements. Chuchalin A; Amelina E; Bianco F Pulm Pharmacol Ther; 2009 Dec; 22(6):526-32. PubMed ID: 19616111 [TBL] [Abstract][Full Text] [Related]
14. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Berlana D; Llop JM; Manresa F; Jódar R Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493 [TBL] [Abstract][Full Text] [Related]
15. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404 [TBL] [Abstract][Full Text] [Related]
16. Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa. Izquierdo MJ; Gomez-Alamillo C; Ortiz F; Calabia ER; Ruiz JC; de Francisco AL; Arias M Clin Nephrol; 2006 Dec; 66(6):464-7. PubMed ID: 17176920 [TBL] [Abstract][Full Text] [Related]
17. Acute renal failure associated with inhaled tobramycin. Cannella CA; Wilkinson ST Am J Health Syst Pharm; 2006 Oct; 63(19):1858-61. PubMed ID: 16990632 [TBL] [Abstract][Full Text] [Related]
18. Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients. Scheenstra RJ; Rijntjes E; Tavy DL; Kingma H; Heijerman HG Acta Otolaryngol; 2009 Jan; 129(1):4-7. PubMed ID: 18607923 [TBL] [Abstract][Full Text] [Related]
19. Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. Santos RP; Awa E; Anbar RD BMC Pediatr; 2007 Mar; 7():11. PubMed ID: 17331261 [TBL] [Abstract][Full Text] [Related]
20. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Gappa M; Steinkamp G; Tümmler B; von der Hardt H Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]